Attention: open in a new window. E-mailPrintPDF
In Q4 last year, pharmaceutical Selvita’s consolidated net profit stood at PLN6.06m, compared to PLN3.1m in the corresponding period in 2018, reads the company’s report based on the combined data.…

Order subscription to read this article




Order at
Order from our partners:

Call us:

Find us: